From July 1, 2023 to December 31, 2023, the company has repurchased 625,000 shares, representing 0.46% for CNY 21.02 million. With this, the company has completed the repurchase of 805,400 shares, representing 0.59% for CNY 27 million under the buyback announced on June 6, 2023.
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.
Equities
301093
CNE100004YH2
Tires & Rubber Products
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.39 CNY | +0.27% |
|
+1.60% | -43.07% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.07% | 325M | |
+5.33% | 27.06B | |
+15.32% | 6B | |
+80.19% | 4.22B | |
+2.47% | 3.44B | |
-10.66% | 3.32B | |
-17.04% | 3.26B | |
+21.29% | 2.92B | |
+3.20% | 2.67B | |
+6.91% | 2.49B |
- Stock Market
- Equities
- 301093 Stock
- News Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.
- Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023.